EU regulator backs Johnson & Johnson COVID-19 shot, finds possible link to clots

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 52 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 66%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

Europe's drug regulator has found a possible link between Johnson & Johnson's COVID-19 vaccine and rare blood clotting issues in adults who ...

AMSTERDAM: Europe's drug regulator has found a possible link between Johnson & Johnson's COVID-19 vaccine and rare blood clotting issues in adults who received doses in the United States, but backed its overall benefits against any risks.

While the regulator said it considers the vaccine safe, it was up to the European Union's member states to decide how to use it, taking a similar stance to that with AstraZeneca. The EMA examined eight cases of clotting that occurred in US adults under 60 years, mostly women, within three weeks of vaccination with J&J's single shot. The cases were reported out of more than 7 million doses administered in the United States as of Apr 13.If treated early, health care professionals can help people in their recovery and avoid further complications, Sabine Straus, chair of EMA's safety committee, told the briefing.

"One plausible explanation for the combination of blood clots and low blood platelets is an immune response, leading to a condition similar to one seen sometimes in patients treated with heparin," the EMA said.There have been more than 300 cases worldwide of rare blood clotting incidents combined with low platelet counts after use of all COVID-19 vaccines, it added.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Risk from COVID-19 variants remains after first Pfizer COVID-19 vaccine, UK study findsLONDON :A single dose of Pfizer's coronavirus vaccine may not generate a sufficient immune response to protect against dominant new variants, ... 所以那些還沒有完成接種第二針疫苗的國家是不能對印度,巴基斯坦,尼泊爾,斯里蘭卡開放的。 3rd and 4th doses coming your way. Then 5th and 6th......... WHILE VIRYS MUTATES
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

EU countries ready to start using Johnson & Johnson COVID-19 vaccine as deliveries resumeEuropean countries prepared on Wednesday (Apr 21) to start using Johnson & Johnson's COVID-19 vaccine and speed up their vaccination campaigns ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

How worried should we be about blood clots linked to Astrazeneca, Johnson & Johnson COVID-19 vaccines?European regulators said the benefits of using Johnson & Johnson's and AstraZeneca's COVID-19 vaccines outweigh risks, even as they added warning ... Very very worried 😟
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Doctors say clot treatment advice key to US resuming Johnson & Johnson COVID-19 vaccinesWASHINGTON: Resuming the use of Johnson & Johnson's COVID-19 vaccine in the United States will require clear guidelines for the medical community ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Johnson & Johnson COVID-19 vaccine reviewed for links to additional reports of severe side effects: CDCThe United States is reviewing reports of a handful of potential cases of severe side effects among people who received Johnson & Johnson's ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »